NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...
AML is a genetically heterogeneous disease, particularly in older patients. In patients older than 60 years, survival rates are variable after the most important curative approach, intensive ...
Artificial intelligence (AI) and socioeconomic factors enhance risk stratification for patients with acute myeloid leukemia (AML) post transplant, aiming to reduce hospital readmissions and disease ...
The ELN 2024 framework offers better stratification for AP/BP MPN, but gaps remain between intermediate and adverse groups. The study analyzed 211 patients, showing modest response rates and ...
Bionano announced a significant study published in the American Journal of Hematology demonstrating the utility of optical genome mapping (OGM) in detecting structural variants associated with ...
This study is led by Dr. Hua You (Children’s Hospital of Chongqing Medical University, Chongqing, China). As our understanding of AML biology, cytogenetic and molecular profiles, and the emergence of ...
Based on the OGM findings, clinical researchers found higher than anticipated rates of CAG in AML (16% of cases overall and approximately two-thirds of cases with high-risk cytogenetic profiles), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback